Pramlintide and Insulin Detemir Interaction

Drug interaction information between Pramlintide and Insulin Detemir.

Pramlintide and Insulin Detemir have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Pramlintide and Insulin Detemir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Pramlintide

Amylin Analog

Drug B

Insulin Detemir

Long-Acting Insulin

How They Interact

Both drugs lower blood sugar, so taking them together increases the chance of your blood sugar dropping to a dangerous level.

Frequently Asked Questions

What SPL severity band is on file for Pramlintide + Insulin Detemir?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Pramlintide has 13 labeled pairs on file vs Insulin Detemir's 11. In the moderate band specifically: Pramlintide has 9 (also Insulin Aspart, Insulin Degludec, Insulin Glargine, Insulin Glulisine); Insulin Detemir has 3 (also Fluoxetine, Octreotide).

What mechanism field is on file for Pramlintide and Insulin Detemir?

Both drugs lower blood sugar, so taking them together increases the chance of your blood sugar dropping to a dangerous level.

Pramlintide's labeled portfolio outnumbers Insulin Detemir

SPL source-record counts only. This page's band is moderate · classes on file: Pramlintide (Amylin Analog); Insulin Detemir (Long-Acting Insulin).

Pramlintide

0 major · 9 moderate · 4 minor · 13 total

Insulin Detemir

0 major · 3 moderate · 8 minor · 11 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.